Arima Genomics Announces Appointment of Genomics Leader Melissa Won as Vice President of Product Development

Carlsbad, Calif. – January 6, 2023 – Arima Genomics, Inc., the leader in 3D genomics, today announced the appointment of Melissa Won, PhD, to the newly created position of Vice President of Product Development.

Melissa returns to Arima Genomics, having previously served as Vice President of Operations, with extensive life sciences leadership spanning product development and clinical testing. Most recently, Melissa was Head of Program Management for Cradle Genomics, where she led the cross-functional team that developed the company’s first clinical services test and launched multiple clinical research studies. Melissa previously led sample-to-report product launches and held senior product development and scientist roles at Illumina. She holds a PhD in Organic Chemistry from the Massachusetts Institute of Technology and a BS in Chemistry from UC San Diego.

“I am thrilled to return to Arima Genomics during such a pivotal time in the company’s growth and expansion into clinically relevant applications,” said Melissa Won, PhD, Vice President of Product Development at Arima Genomics. “I look forward to working closely with the smart, dedicated team to bring meaningful new products to the market that will positively impact human health and advance Arima’s mission.”

As Vice President of Product Development, Melissa will oversee the ongoing development of the Arima Genomics product portfolio. Her efforts will be critical as the organization scales to develop new solutions that serve a broad spectrum of scientific, translational medicine, and clinical applications.

“We are delighted to welcome Melissa back to the Arima Genomics team where her impressive track record of developing and launching innovative products will help us advance our science and improve human health,” said Chris Roberts, SVP of Corporate Strategy of Arima Genomics. “Her strategic experience and scientific knowledge, not only of our technology but also the needs of our customers, will accelerate how we empower customers with 3D genomics to understand human health and disease.”

About Arima Genomics

Arima Genomics, Inc. is advancing life sciences research through the power of 3D genomics by providing unparalleled access to the sequence and structure of any genome. Arima Genomics offers the most advanced technologies for preserving the structural organization of the genome to drive discovery in genome biology and human health. To learn more, visit www.arimagenomics.com and connect with us on Twitter, LinkedIn, and YouTube.

Contacts

For media
Gwen Gordon
gwen@gwengordonpr.com

For general inquiries
Pamela Bentley Mills, PhD
pamela@arimagenomics.com